We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Spring sunshine on time for 'happy' outdoor events
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (Wainzua) to treat adults with polyneuropathy associated with hereditary transthyretin amyloidosis (ATTRv), which is a rare progressive …
This bulletin (formally Weekly Winter Briefing) brings together the latest surveillance data, along with the latest public health advice for flu, COVID-19, RSV and other viruses common in winter.
Ending doctor strikes saved 500,000 appointments and operations, and cut waiting lists by 193,000.
Infected Blood Compensation Authority's update that was circulated on 2 April 2025
UKHSA launches a call for evidence to shape England’s 2026 to 2031 TB Action Plan as TB rates continue to rise.
Seven new CERSIs came together to showcase how partnerships will modernise regulation in AI, clinical trials, and advanced therapies, bringing innovations to patients sooner.
Lawrence Tallon today (1 April 2025) begins his role as Chief Executive Officer of the Medicines and Healthcare products Regulatory Agency (MHRA).
As Dame June Raine gets ready to pass the baton on after nearly 40 years at the agency, the last five of which she has been CEO, she reflects on how new innovations are transforming regulation and how honoured she feels to h…
A new collaboration between The Pandemic Institute (TPI) and Dstl, is set to fund vital research into emerging infectious diseases.
Patients to benefit from new services thanks to funding deal agreed between the government and Community Pharmacy England.
As with all products, the MHRA will keep its safety under close review.
In 2024, 904 dengue cases were reported in returning travellers across England, Wales and Northern Ireland, up from 631 in 2023.
Although numbers remain low, cases are being detected more frequently.
The new MHRA Safety Roundup provides a monthly summary of the latest safety advice for all medicines, medical devices, and healthcare products regulated by the MHRA, as part of our 3-year strategy to improve safety communica…
The UK Health Security Agency's (UKHSA) first annual report summarising the latest infectious disease trends, bringing together all the key data from 2023 to early 2025 and outlining steps the organisation is taking to t…
Natural England is joining forces with the NHS to run free sessions across Cornwall for primary aged children and a parent or carer.
New UKHSA study shows the RSV vaccination programme already achieving a 30% reduction in hospital admissions in older people in England as roll-out continues.
A new Priority Pathogens reference tool aims to support national funders of research and development into diagnostics, vaccines and therapeutics.
More officers trained and funding provided as clampdown on illegal tobacco and vape trade accelerates.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).